Estimating the prevalence of pyruvate kinase deficiency from the gene frequency in the general white population
- PMID:10828047
Estimating the prevalence of pyruvate kinase deficiency from the gene frequency in the general white population
Abstract
Pyruvate kinase (PK) deficiency is the most common cause of hereditary nonspherocytic hemolytic anemia. The prevalence of this deficiency is unknown, though some estimates have been made based on the frequency of low red cell PK activity in the population. An additional 20 patients with hereditary nonspherocytic hemolytic anemia caused by PK deficiency have been genotyped. One previously unreported mutation 1153C-->T (R385W) was encountered. The relative frequency of PK mutations in patients with hemolytic anemia caused by PK deficiency was calculated from the 18 white patients reported here and from 102 patients previously reported in the literature. DNA samples from 3785 subjects from different ethnic groups have been screened for the 4 more frequently encountered mutations-c.1456 C-->T(1456T), c.1468 C-->T(1468T), c.1484 C-->T(1484T), and c.1529 G6A (1529A)-by allele-specific oligonucleotide hybridization. Among white patients the frequency of the 1456T mutation was 3.50 x 10(-3); that of the 1529A mutation was 2.03 x 10(-3). Among African Americans the frequency of the 1456T mutation was 3.90 x 10(-3) The only mutation found in the limited number of Asians tested was 1468T at a frequency of 7.94 x 10(-3). Based on the gene frequency of the 1529A mutation in the white population and on its relative abundance in patients with hemolytic anemia caused by PK deficiency, the prevalence of PK deficiency is estimated at 51 cases per million white population. This number would be increased by inbreeding and decreased by failure of patients with PK deficiency to survive.
Comment in
- Prevalence of pyruvate kinase deficiency in northern European population in the north of England. Northern Region Haematologists Group.Carey PJ, Chandler J, Hendrick A, Reid MM, Saunders PW, Tinegate H, Taylor PR, West N.Carey PJ, et al.Blood. 2000 Dec 1;96(12):4005-6.Blood. 2000.PMID:11186276No abstract available.
Similar articles
- Molecular study of pyruvate kinase deficient patients with hereditary nonspherocytic hemolytic anemia.Baronciani L, Beutler E.Baronciani L, et al.J Clin Invest. 1995 Apr;95(4):1702-9. doi: 10.1172/JCI117846.J Clin Invest. 1995.PMID:7706479Free PMC article.
- Molecular basis of pyruvate kinase deficiency among Tunisians: description of new mutations affecting coding and noncoding regions in the PKLR gene.Jaouani M, Manco L, Kalai M, Chaouch L, Douzi K, Silva A, Macedo S, Darragi I, Boudriga I, Chaouachi D, Fitouri Z, Van Wijk R, Ribeiro ML, Abbes S.Jaouani M, et al.Int J Lab Hematol. 2017 Apr;39(2):223-231. doi: 10.1111/ijlh.12610. Epub 2017 Jan 30.Int J Lab Hematol. 2017.PMID:28133914
- Erythrocytic pyruvate kinase mutations causing hemolytic anemia, osteosclerosis, and secondary hemochromatosis in dogs.Gultekin GI, Raj K, Foureman P, Lehman S, Manhart K, Abdulmalik O, Giger U.Gultekin GI, et al.J Vet Intern Med. 2012 Jul-Aug;26(4):935-44. doi: 10.1111/j.1939-1676.2012.00958.x.J Vet Intern Med. 2012.PMID:22805166Free PMC article.
- Red cell pyruvate kinase deficiency: from genetics to clinical manifestations.Zanella A, Bianchi P.Zanella A, et al.Baillieres Best Pract Res Clin Haematol. 2000 Mar;13(1):57-81. doi: 10.1053/beha.1999.0057.Baillieres Best Pract Res Clin Haematol. 2000.PMID:10916678Review.
- Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: tabulation of mutant enzymes.Miwa S, Fujii H.Miwa S, et al.Am J Hematol. 1996 Feb;51(2):122-32. doi: 10.1002/(SICI)1096-8652(199602)51:2<122::AID-AJH5>3.0.CO;2-#.Am J Hematol. 1996.PMID:8579052Review.
Cited by
- Concomitant Hereditary Spherocytosis and Pyruvate Kinase Deficiency in a Spanish Family with Chronic Hemolytic Anemia: Contribution of Laser Ektacytometry to Clinical Diagnosis.Vives Corrons JL, Krishnevskaya E, Montllor L, Leguizamon V, Garcia Bernal M.Vives Corrons JL, et al.Cells. 2022 Mar 28;11(7):1133. doi: 10.3390/cells11071133.Cells. 2022.PMID:35406697Free PMC article.
- Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzyme.Meza NW, Alonso-Ferrero ME, Navarro S, Quintana-Bustamante O, Valeri A, Garcia-Gomez M, Bueren JA, Bautista JM, Segovia JC.Meza NW, et al.Mol Ther. 2009 Dec;17(12):2000-9. doi: 10.1038/mt.2009.200. Epub 2009 Sep 15.Mol Ther. 2009.PMID:19755962Free PMC article.
- The Interplay between Drivers of Erythropoiesis and Iron Homeostasis in Rare Hereditary Anemias: Tipping the Balance.Grootendorst S, de Wilde J, van Dooijeweert B, van Vuren A, van Solinge W, Schutgens R, van Wijk R, Bartels M.Grootendorst S, et al.Int J Mol Sci. 2021 Feb 23;22(4):2204. doi: 10.3390/ijms22042204.Int J Mol Sci. 2021.PMID:33672223Free PMC article.Review.
- Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency.Salek MS, Ionova T, Johns JR, Oliva EN.Salek MS, et al.Qual Life Res. 2019 Feb;28(2):399-410. doi: 10.1007/s11136-018-2025-y. Epub 2018 Nov 19.Qual Life Res. 2019.PMID:30456713Free PMC article.Clinical Trial.
- Five Years' Experience with Gene Panel Sequencing in Hereditary Hemolytic Anemia Screened by Routine Peripheral Blood Smear Examination.Kim N, Kim TY, Han JY, Park J.Kim N, et al.Diagnostics (Basel). 2023 Feb 17;13(4):770. doi: 10.3390/diagnostics13040770.Diagnostics (Basel). 2023.PMID:36832257Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical